Rôle des cytokines dans la physiopathologie du lupus

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Immuno-analyse & Biologie Specialisee

• Publication date

  2000-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0923-2532(00)80019-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis.

  2010cited by this paper
• Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

  2000cited by this paper
• Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus.

  1999cited by this paper
• Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon γ, and IL-10: Role of B Cells in the Maintenance of  T Cell Responses

  1999cited by this paper
• Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC.

  1999cited by this paper
• Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity.

  1999cited by this paper
• Th1 and Th2 cytokines in organ transplantation: paradigm lost?

  1999cited by this paper
• Th1 (IL‐2, interferon‐gamma (IFN‐γ)) and Th2 (IL‐10, IL‐4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)

  1999cited by this paper
• T helper cell differentiation in multiple sclerosis and autoimmunity.

  1998cited by this paper
• Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.

  1998cited by this paper
• Production of reactive oxygen intermediates following CD40 ligation correlates with c‐Jun N‐terminal kinase activation and IL‐6 secretion in murine B lymphocytes

  1998cited by this paper
• Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.

  1998cited by this paper
• Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.

  1998cited by this paper
• Controlled release of leukaemia inhibitory factor (LIF) to tissues.

  1997cited by this paper
• Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease.

  1997cited by this paper
• IL‐12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC)

  1997cited by this paper
• Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(lpr) mice with renal injury.

  1997cited by this paper
• Interleukin-4 Protects against a Genetically Linked Lupus-like Autoimmune Syndrome

  1997cited by this paper
• Constitutive Expression of Interleukin (IL)-4 In Vivo Causes Autoimmune-type Disorders in Mice

  1997cited by this paper
• Leukemia inhibitory factor (LIF) binding protein attenuates the phlogistic and abolishes the chondral effects of LIF in goat joints.

  1997cited by this paper
• Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.

  1997cited by this paper
• Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.

  1996cited by this paper
• The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLMP-lprlpr mice

  1996cited by this paper
• Cytokine gene expression in the MRL/lpr model of lupus nephritis.

  1996cited by this paper
• Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface.

  1996cited by this paper
• Expression of transforming growth factor-β isoforms in human glomerular diseases

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis.

  1996cited by this paper
• IL-12: a key cytokine in immune regulation.

  1996cited by this paper
• Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways.

  1996cited by this paper
• Serum and urinary interleukin-6 in systemic lupus erythematosus

  1996cited by this paper
• Defective antigen-presenting cell function in patients with systemic lupus erythematosus.

  1996cited by this paper
• Defective B7 expression on antigen‐presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients

  1996cited by this paper
• Autocrine secretion and the physiological concentration of cytokines.

  1996cited by this paper
• Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood.

  1996cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.

  1996cited by this paper
• Dysregulation of T Helper Cell Cytokines in Autoimmune Prone NZB x NZW Fl Mice

  1995cited by this paper
• Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

  1995cited by this paper
• High levels of TH2 cytokine gene expression in systemic lupus erythematosus.

  1995cited by this paper
• Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus.

  1995cited by this paper
• Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery

  1995cited by this paper
• Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon‐γ receptor inhibits the onset of glomerulonephritis

  1995cited by this paper
• IgG2 Deficiency Associated with Defects in Production of Interferon‐Gamma; Comparison with Common Variable Immunodeficiency

  1995cited by this paper
• Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.

  1995cited by this paper
• Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus.

  1994cited by this paper
• Lymphokine production by human T cells in disease states.

  1994cited by this paper
• Acquisition of lymphokine-producing phenotype by CD4+ T cells.

  1994cited by this paper
• Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

  1994cited by this paper
• Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation.

  1994cited by this paper
• Cytokine Gene Profile in Circulating Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus: Increased Interleukin-2 but not Interleukin-4 mRNA

  1994cited by this paper
• Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice.

  1994cited by this paper
• Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia.

  1994cited by this paper
• Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.

  1994cited by this paper
• Lymphocyte responses and cytokines.

  1994cited by this paper
• Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

  1994cited by this paper
• Review: Role of Transforming Growth Factor Beta (TGFβ) in Systemic Autoimmunity

  1993cited by this paper
• Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides.

  1993cited by this paper
• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

  1993cited by this paper
• Relationship of interleukin-4 to isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosus.

  1993cited by this paper
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

  1993cited by this paper
• Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.

  1993cited by this paper
• Systemic immunological effects of cytokine genes injected into skeletal muscle.

  1993cited by this paper
• Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

  1993cited by this paper
• The effect of leukemia inhibitory factor on bone in vivo.

  1993cited by this paper
• Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.

  1993cited by this paper
• High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL‐6 under corticosteroid therapy

  1993cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.

  1993cited by this paper
• Urinary levels of IL-6 in patients with active lupus nephritis.

  1993cited by this paper
• Preferential activation of Th2 cells in chronic graft-versus-host reaction.

  1993cited by this paper
• Regulation of C gamma subclass germ-line transcripts in human peripheral blood B cells.

  1993cited by this paper
• Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

  1992cited by this paper
• Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system.

  1992cited by this paper
• The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF?

  1992cited by this paper
• The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

  1992cited by this paper
• Induction of IgG3 secretion by interferon gamma: a model for T cell- independent class switching in response to T cell-independent type 2 antigens

  1992cited by this paper
• HILDA/LIF URINARY EXCRETION DURING ACUTE KIDNEY REJECTION

  1992cited by this paper
• Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids.

  1992cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Replication of basal bodies and centrioles.

  1992cited by this paper
• Plasma concentration of IL‐6 in systemic lupus erythematosus; an indicator of disease activity?

  1992cited by this paper
• Valid estimation of IL2 secretion by PHA-stimulated T-cell clones absolutely requires the use of anti-CD25 monoclonal antibody to prevent IL2 consumption.

  1992cited by this paper
• Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.

  1992cited by this paper
• Receptors for the TGF-β family

  1992cited by this paper
• Cytokine abnormalities in human lupus.

  1992cited by this paper
• Clearance and fate of leukemia‐inhibitory factor (LIF) after injection into mice

  1991cited by this paper
• Macrophage deactivation by interleukin 10

  1991cited by this paper
• Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro.

  1991cited by this paper
• Elevated production of interferon‐γ and interleukin 4 by mature T cells from autoimmune Ipr mice correlates with Pgp‐1 (CD44) expression

  1991cited by this paper
• Subsets of CD4+ T Cells and their Roles in the Induction and Prevention of Autoimmunity

  1991cited by this paper
• Interleukin 2 abrogates the nonresponsive state of T cells expressing a forbidden T cell receptor repertoire and induces autoimmune disease in neonatally thymectomized mice

  1991cited by this paper
• Human TH1 and TH2 subsets: doubt no more.

  1991cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors.

  1991cited by this paper
• Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

  1991cited by this paper
• Generation of sensory neurons is stimulated by leukemia inhibitory factor.

  1991cited by this paper
• Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus

  1990cited by this paper
• Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.

  1990cited by this paper
• Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.

  1990cited by this paper

• No citing papers are available for this paper.